166 related articles for article (PubMed ID: 20955553)
1. A structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins.
Inagaki N; Takeuchi H; Yokoyama M; Sato H; Ryo A; Yamamoto H; Kawada M; Matano T
Retrovirology; 2010 Oct; 7():90. PubMed ID: 20955553
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of AIDS vaccine-induced cytotoxic T-lymphocyte efficacy in vivo due to a change in viral epitope flanking sequences.
Moriya C; Igarashi H; Takeda A; Tsukamoto T; Kawada M; Yamamoto H; Inoue M; Iida A; Shu T; Hasegawa M; Nagai Y; Matano T
Microbes Infect; 2008 Mar; 10(3):285-92. PubMed ID: 18316225
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen bonding at a conserved threonine in lentivirus capsid is required for virus replication.
Rue SM; Roos JW; Amzel LM; Clements JE; Barber SA
J Virol; 2003 Jul; 77(14):8009-18. PubMed ID: 12829840
[TBL] [Abstract][Full Text] [Related]
4. Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial.
Kawada M; Tsukamoto T; Yamamoto H; Iwamoto N; Kurihara K; Takeda A; Moriya C; Takeuchi H; Akari H; Matano T
J Virol; 2008 Oct; 82(20):10199-206. PubMed ID: 18667518
[TBL] [Abstract][Full Text] [Related]
5. Contribution of glutamine residues in the helix 4-5 loop to capsid-capsid interactions in simian immunodeficiency virus of macaques.
Tipper C; Sodroski JG
J Virol; 2014 Sep; 88(18):10289-302. PubMed ID: 24991000
[TBL] [Abstract][Full Text] [Related]
6. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
[TBL] [Abstract][Full Text] [Related]
7. Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.
Kuwata T; Dehghani H; Brown CR; Plishka R; Buckler-White A; Igarashi T; Mattapallil J; Roederer M; Hirsch VM
J Virol; 2006 Feb; 80(3):1463-75. PubMed ID: 16415023
[TBL] [Abstract][Full Text] [Related]
8. Rhesus Cytomegalovirus-Specific CD8
Rosen BC; Pedreño-Lopez N; Ricciardi MJ; Reed JS; Sacha JB; Rakasz EG; Watkins DI
Front Immunol; 2020; 11():1960. PubMed ID: 32922404
[TBL] [Abstract][Full Text] [Related]
9. TRIM5α Resistance Escape Mutations in the Capsid Are Transferable between Simian Immunodeficiency Virus Strains.
Wu F; Kirmaier A; White E; Ourmanov I; Whitted S; Matsuda K; Riddick N; Hall LR; Morgan JS; Plishka RJ; Buckler-White A; Johnson WE; Hirsch VM
J Virol; 2016 Dec; 90(24):11087-11095. PubMed ID: 27681142
[TBL] [Abstract][Full Text] [Related]
10. Compensatory substitutions restore normal core assembly in simian immunodeficiency virus isolates with Gag epitope cytotoxic T-lymphocyte escape mutations.
Yeh WW; Cale EM; Jaru-Ampornpan P; Lord CI; Peyerl FW; Letvin NL
J Virol; 2006 Aug; 80(16):8168-77. PubMed ID: 16873273
[TBL] [Abstract][Full Text] [Related]
11. nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes.
Sugimoto C; Tadakuma K; Otani I; Moritoyo T; Akari H; Ono F; Yoshikawa Y; Sata T; Izumo S; Mori K
J Virol; 2003 Apr; 77(7):4169-80. PubMed ID: 12634375
[TBL] [Abstract][Full Text] [Related]
12. A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses.
Kuwata T; Byrum R; Whitted S; Goeken R; Buckler-White A; Plishka R; Iyengar R; Hirsch VM
J Virol; 2007 Sep; 81(17):8891-904. PubMed ID: 17596304
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte-tropic simian immunodeficiency virus causes persistent infection in the brains of rhesus monkeys.
Stephens EB; Liu ZQ; Zhu GW; Adany I; Joag SV; Foresman L; Berman NE; Narayan O
Virology; 1995 Nov; 213(2):600-14. PubMed ID: 7491784
[TBL] [Abstract][Full Text] [Related]
14. Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys.
Alexander L; Illyinskii PO; Lang SM; Means RE; Lifson J; Mansfield K; Desrosiers RC
J Virol; 2003 Jun; 77(12):6823-35. PubMed ID: 12768002
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.
Matano T; Kobayashi M; Igarashi H; Takeda A; Nakamura H; Kano M; Sugimoto C; Mori K; Iida A; Hirata T; Hasegawa M; Yuasa T; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; O'Connor DH; Watkins DI; Nagai Y
J Exp Med; 2004 Jun; 199(12):1709-18. PubMed ID: 15210746
[TBL] [Abstract][Full Text] [Related]
16. Mutation in the Disordered Linker Region of Capsid Disrupts Viral Kinetics of a Neuropathogenic SIV in Rhesus Macaques.
Lee CA; Hirsch VM
Microbiol Spectr; 2022 Apr; 10(2):e0047822. PubMed ID: 35297654
[TBL] [Abstract][Full Text] [Related]
17. Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope.
Peyerl FW; Bazick HS; Newberg MH; Barouch DH; Sodroski J; Letvin NL
J Virol; 2004 Dec; 78(24):13901-10. PubMed ID: 15564498
[TBL] [Abstract][Full Text] [Related]
18. A Novel Immunogen Selectively Eliciting CD8
Ishii H; Terahara K; Nomura T; Takeda A; Okazaki M; Yamamoto H; Tokusumi T; Shu T; Matano T
J Virol; 2020 Mar; 94(8):. PubMed ID: 32024773
[TBL] [Abstract][Full Text] [Related]
19. Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.
Loffredo JT; Bean AT; Beal DR; León EJ; May GE; Piaskowski SM; Furlott JR; Reed J; Musani SK; Rakasz EG; Friedrich TC; Wilson NA; Allison DB; Watkins DI
J Virol; 2008 Feb; 82(4):1723-38. PubMed ID: 18057253
[TBL] [Abstract][Full Text] [Related]
20. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac.
Marthas ML; Ramos RA; Lohman BL; Van Rompay KK; Unger RE; Miller CJ; Banapour B; Pedersen NC; Luciw PA
J Virol; 1993 Oct; 67(10):6047-55. PubMed ID: 8371353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
